Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 40Advanced Solid Tumor 25Solid Tumors 22Mesothelioma 17Mesothelioma, Malignant 15Solid Tumor 12Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 9Pancreatic Neoplasms 6Malignant Solid Neoplasm 6Colorectal Neoplasms 6Stomach Neoplasms 5Solid Tumours 5Solid Tumor, Adult 5Neoplasms 5Sarcoma 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Triple Negative Breast Neoplasms 3Retinoblastoma 3Kidney Neoplasms 3Advanced or Metastatic Solid Tumors 3Advanced Malignant Solid Tumors 3Advanced Malignant Solid Neoplasm 3Thymoma 2Solitary Fibrous Tumor, Pleural 2Solid Tumor Malignancies 2Solid Tumor Cancer 2Small Cell Lung Carcinoma 2

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Other solid neoplasm × 30 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡